Botswana vs Congo: Population requiring preventive chemotherapy for schistosomiasis
Botswana
128,785
in 2024
Congo
151,745
in 2024
Botswana rank
47th
Congo rank
45th
Population requiring preventive chemotherapy for schistosomiasis over time
- Botswana
- Congo
How they compare
Congo currently reports 151,745 against 128,785 in Botswana, a difference of 22,960.
That makes Congo's figure about 1.2 times Botswana's.
The two have swapped places 4 times across 15 shared years of data; in 2010 it was Congo ahead.
Botswana ranks 47th and Congo ranks 45th of 52 countries.
Across the 2 decades both report, Botswana averaged higher in 1 and Congo in 1.
Head to head by decade
| Decade | Botswana | Congo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 172,114 | 267,052 | 94,938 | Congo |
| 2020s | 1.01 million | 348,377 | 664,523 | Botswana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Botswana or Congo?
- Congo, at 151,745 against 128,785 in Botswana as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Botswana and Congo?
- 22,960, with Congo ahead.
- How many years of comparable data are there for Botswana and Congo?
- 15 years are reported by both, from 2010 to 2024.
- How do Botswana and Congo rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Botswana ranks 47th and Congo ranks 45th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.